JKT:HEAL
PT Medikaloka Hermina Tbk · JKT · Healthcare · IDR · FY for 2025
Figures on this page computed 2026-11-08 13:22 UTC
Last close
n/aIDR
Market data
16.9xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- IDR
- computed
- Computed from the filing for 2025
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- IDR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
6.0%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- IDR
- Computed from the filing for 2025
- Computed from the filing for 2025
-8.6%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- IDR
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- IDR
- Computed from the filing for 2025
- Computed from the filing for 2025
2.1%Dividend yield
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- IDR
- computed
Growth is the furthest below its sector's middle: 0.34 against 0.47 on the market's range.
Follow one rupiah
lens 1 of 9The five stops
5 of 5 read- After what it costs to make2,135,008,000,00029.9%
- After running the business941,356,000,00013.2%
- After interest and tax429,547,000,0006.0%
- After what it must reinvest-612,151,000,000-8.6%
- Kept after the dividend-767,622,000,000-10.8%
Of every unit of sales, -0.11 is still there after the dividend.
Of every unit of sales, -0.11 is still there after the dividend.
Every figure in this lens
Except where said otherwise: Computed from the filing for 2025
Sales7,133,538,000,000
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- IDR
After what it costs to make2,135,008,000,000
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- IDR
After running the business941,356,000,000
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- IDR
After interest and tax429,547,000,000
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- IDR
After what it must reinvest-612,151,000,000
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- IDR
Kept after the dividend-767,622,000,000
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- IDR